7-44513463-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001101648.2(NPC1L1):āc.3983A>Gā(p.Asn1328Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001101648.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC1L1 | NM_001101648.2 | c.3983A>G | p.Asn1328Ser | missense_variant | 19/19 | ENST00000381160.8 | NP_001095118.1 | |
NPC1L1 | NM_013389.3 | c.4064A>G | p.Asn1355Ser | missense_variant | 20/20 | NP_037521.2 | ||
NPC1L1 | XM_011515326.4 | c.3788A>G | p.Asn1263Ser | missense_variant | 18/18 | XP_011513628.1 | ||
NPC1L1 | XM_011515328.3 | c.2342A>G | p.Asn781Ser | missense_variant | 16/16 | XP_011513630.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC1L1 | ENST00000381160.8 | c.3983A>G | p.Asn1328Ser | missense_variant | 19/19 | 1 | NM_001101648.2 | ENSP00000370552.3 | ||
NPC1L1 | ENST00000289547.8 | c.4064A>G | p.Asn1355Ser | missense_variant | 20/20 | 1 | ENSP00000289547.4 | |||
NPC1L1 | ENST00000546276.5 | c.3845A>G | p.Asn1282Ser | missense_variant | 18/18 | 1 | ENSP00000438033.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461576Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727102
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at